Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
VMF
0
Europe
0
Australia
0
South Africa
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
Finished Drug Prices
NA
1. Codinovo
2. Dicodid
3. Dihydrocodeinone
4. Hycodan
5. Hycon
6. Hydrocodeinonebitartrate
7. Hydrocodon
8. Hydrocodone
9. Hydrocodone Tartrate (1:1), Hydrate (2:5)
10. Hydrocon
11. Robidone
1. (4r,4ar,7ar,12bs)-9-methoxy-3-methyl-1,2,4,4a,5,6,7a,13-octahydro-4,12-methanobenzofuro[3,2-e]isoquinolin-7-one;2,3-dihydroxybutanedioic Acid
2. .codon
3. Schembl154972
4. Chembl2062267
1. Hydrocone
2. Multacodin
3. Hydrocodone
Molecular Weight | 449.4 g/mol |
---|---|
Molecular Formula | C22H27NO9 |
Hydrogen Bond Donor Count | 4 |
Hydrogen Bond Acceptor Count | 10 |
Rotatable Bond Count | 4 |
Exact Mass | 449.16858144 g/mol |
Monoisotopic Mass | 449.16858144 g/mol |
Topological Polar Surface Area | 154 Ų |
Heavy Atom Count | 32 |
Formal Charge | 0 |
Complexity | 642 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 4 |
Undefined Atom Stereocenter Count | 2 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
Analgesics, Opioid
Compounds with activity like OPIATE ALKALOIDS, acting at OPIOID RECEPTORS. Properties include induction of ANALGESIA or NARCOSIS. (See all compounds classified as Analgesics, Opioid.)
Antitussive Agents
Agents that suppress cough. They act centrally on the medullary cough center. EXPECTORANTS, also used in the treatment of cough, act locally. (See all compounds classified as Antitussive Agents.)
Narcotics
Agents that induce NARCOSIS. Narcotics include agents that cause somnolence or induced sleep (STUPOR); natural or synthetic derivatives of OPIUM or MORPHINE or any substance that has such effects. They are potent inducers of ANALGESIA and OPIOID-RELATED DISORDERS. (See all compounds classified as Narcotics.)
GDUFA
DMF Review : Reviewed
Rev. Date : 2013-04-23
Pay. Date : 2013-04-09
DMF Number : 19848
Submission : 2006-10-03
Status : Active
Type : II
NDC Package Code : 49812-0132
Start Marketing Date : 1996-01-01
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Noramco is a partner to the pharmaceutical industry for controlled substance development & manufacturing.
GDUFA
DMF Review : Reviewed
Rev. Date : 2013-02-08
Pay. Date : 2012-11-23
DMF Number : 21158
Submission : 2007-12-18
Status : Active
Type : II
NDC Package Code : 51634-0014
Start Marketing Date : 1987-07-24
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Noramco is a partner to the pharmaceutical industry for controlled substance development & manufacturing.
GDUFA
DMF Review : Reviewed
Rev. Date : 2014-03-31
Pay. Date : 2014-03-20
DMF Number : 23681
Submission : 2010-03-31
Status : Active
Type : II
NDC Package Code : 51634-0014
Start Marketing Date : 1987-07-24
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : Reviewed
Rev. Date : 2012-11-11
Pay. Date : 2012-11-27
DMF Number : 4884
Submission : 1983-03-15
Status : Active
Type : II
NDC Package Code : 0406-1559
Start Marketing Date : 2011-12-17
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Registrant Name : Nosa Chemical Co., Ltd.
Registration Date : 2022-05-25
Registration Number : 20220525-211-J-1305
Manufacturer Name : SpecGx LLC
Manufacturer Address : 3600 North 2nd Street, St. Louis, MO 63147, USA
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 17285
Submission : 2004-03-25
Status : Active
Type : II
NDC Package Code : 0406-1559
Start Marketing Date : 2011-12-17
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Registrant Name : Nosa Chemical Co., Ltd.
Registration Date : 2022-05-25
Registration Number : 20220525-211-J-1305
Manufacturer Name : SpecGx LLC
Manufacturer Address : 3600 North 2nd Street, St. Louis, MO 63147, USA
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 24846
Submission : 2011-09-30
Status : Active
Type : II
NDC Package Code : 0406-1559
Start Marketing Date : 2011-12-17
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Registrant Name : Nosa Chemical Co., Ltd.
Registration Date : 2022-05-25
Registration Number : 20220525-211-J-1305
Manufacturer Name : SpecGx LLC
Manufacturer Address : 3600 North 2nd Street, St. Louis, MO 63147, USA
GDUFA
DMF Review : Reviewed
Rev. Date : 2014-10-20
Pay. Date : 2014-10-14
DMF Number : 19460
Submission : 2006-05-26
Status : Active
Type : II
NDC Package Code : 0792-0543
Start Marketing Date : 2006-05-26
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : Complete
Rev. Date : 2013-04-23
Pay. Date : 2013-04-09
DMF Number : 19848
Submission : 2006-10-03
Status : Active
Type : II
Noramco is a partner to the pharmaceutical industry for controlled substance development & manufacturing.
GDUFA
DMF Review : Complete
Rev. Date : 2014-03-31
Pay. Date : 2014-03-20
DMF Number : 23681
Submission : 2010-03-31
Status : Active
Type : II
Noramco is a partner to the pharmaceutical industry for controlled substance development & manufacturing.
GDUFA
DMF Review : Complete
Rev. Date : 2013-02-08
Pay. Date : 2012-11-23
DMF Number : 21158
Submission : 2007-12-18
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2012-11-11
Pay. Date : 2012-11-27
DMF Number : 4884
Submission : 1983-03-15
Status : Active
Type : II
USDMF
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 5891
Submission : 1985-06-28
Status : Inactive
Type : II
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Registrant Name : Nosa Chemical Co., Ltd.
Registration Date : 2022-05-25
Registration Number : 20220525-211-J-1305
Manufacturer Name : SpecGx LLC
Manufacturer Address : 3600 North 2nd Street, St. Louis, MO 63147, USA
NDC Package Code : 49812-0132
Start Marketing Date : 1996-01-01
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Noramco is a partner to the pharmaceutical industry for controlled substance development & manufacturing.
NDC Package Code : 51634-0014
Start Marketing Date : 1987-07-24
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 63275-4100
Start Marketing Date : 2017-01-01
End Marketing Date : 2025-09-01
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 59116-4490
Start Marketing Date : 2012-10-26
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 59116-4751
Start Marketing Date : 2014-10-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 61960-9193
Start Marketing Date : 2011-06-21
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 51552-0677
Start Marketing Date : 2004-09-01
End Marketing Date : 2025-08-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 0406-1582
Start Marketing Date : 1973-06-30
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 0406-1559
Start Marketing Date : 2011-12-17
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 51927-0331
Start Marketing Date : 2024-04-05
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
CAS Number : 3861-72-1
End Use API : Hydrocodone Bitartrate
About The Company : Established in 1997, Temad Co. is one of the largest producers of APIs in Iran & an innovative manufacturer of narcotic and non-narcotic products of world-class...
RLD : Yes
TE Code :
HYDROCODONE BITARTRATE; IBUPROFEN
Brand Name : VICOPROFEN
Dosage Form : TABLET;ORAL
Dosage Strength : 7.5MG;200MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Approval Date : 1997-09-23
Application Number : 20716
RX/OTC/DISCN : DISCN
RLD : Yes
TE Code :
RLD : No
TE Code :
ACETAMINOPHEN; HYDROCODONE BITARTRATE
Brand Name : VICODIN HP
Dosage Form : TABLET;ORAL
Dosage Strength : 660MG;10MG
Approval Date : 1996-09-23
Application Number : 40117
RX/OTC/DISCN : DISCN
RLD : No
TE Code :
RLD : No
TE Code :
ACETAMINOPHEN; HYDROCODONE BITARTRATE
Brand Name : VICODIN
Dosage Form : TABLET;ORAL
Dosage Strength : 500MG;5MG
Approval Date : 1983-01-07
Application Number : 88058
RX/OTC/DISCN : DISCN
RLD : No
TE Code :
RLD : No
TE Code :
ACETAMINOPHEN; HYDROCODONE BITARTRATE
Brand Name : VICODIN ES
Dosage Form : TABLET;ORAL
Dosage Strength : 750MG;7.5MG
Approval Date : 1988-12-09
Application Number : 89736
RX/OTC/DISCN : DISCN
RLD : No
TE Code :
LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
RLD : No
TE Code :
ASPIRIN; HYDROCODONE BITARTRATE
Brand Name : HYDROCODONE BITARTRATE AND ASPIRIN
Dosage Form : TABLET;ORAL
Dosage Strength : 500MG;5MG
Approval Date : 2021-05-28
Application Number : 205479
RX/OTC/DISCN : RX
RLD : No
TE Code :
RLD : No
TE Code :
ACETAMINOPHEN; HYDROCODONE BITARTRATE
Brand Name : HYDROCODONE BITARTRATE AND ACETAMINOPHEN
Dosage Form : SOLUTION;ORAL
Dosage Strength : 300MG/15ML;10MG/15ML
Approval Date : 2010-02-25
Application Number : 40881
RX/OTC/DISCN : RX
RLD : No
TE Code :
RLD : No
TE Code :
ACETAMINOPHEN; HYDROCODONE BITARTRATE
Brand Name : HYDROCODONE BITARTRATE AND ACETAMINOPHEN
Dosage Form : SOLUTION;ORAL
Dosage Strength : 500MG/15ML;7.5MG/15ML
Approval Date : 1992-08-28
Application Number : 81051
RX/OTC/DISCN : DISCN
RLD : No
TE Code :
RLD : No
TE Code :
ACETAMINOPHEN; HYDROCODONE BITARTRATE
Brand Name : HYDROCODONE BITARTRATE AND ACETAMINOPHEN
Dosage Form : CAPSULE;ORAL
Dosage Strength : 500MG;5MG
Approval Date : 1989-11-30
Application Number : 81067
RX/OTC/DISCN : DISCN
RLD : No
TE Code :
RLD : No
TE Code :
ACETAMINOPHEN; HYDROCODONE BITARTRATE
Brand Name : HYDROCODONE BITARTRATE AND ACETAMINOPHEN
Dosage Form : CAPSULE;ORAL
Dosage Strength : 500MG;5MG
Approval Date : 1986-02-21
Application Number : 89008
RX/OTC/DISCN : DISCN
RLD : No
TE Code :
RLD : No
TE Code :
ACETAMINOPHEN; HYDROCODONE BITARTRATE
Brand Name : HYDROCODONE BITARTRATE AND ACETAMINOPHEN
Dosage Form : TABLET;ORAL
Dosage Strength : 500MG;5MG
Approval Date : 1986-07-16
Application Number : 89271
RX/OTC/DISCN : DISCN
RLD : No
TE Code :
DRUG PRODUCT COMPOSITIONS
Related Excipient Companies
Dosage Form : Tablet
Grade : Oral, Parenteral
Application : Controlled & Modified Release
Excipient Details : PLGA-PEG is used in the synthesis of targeted nanoparticles which are used for differential delivery and controlled release of drugs.
Pharmacopoeia Ref : NA
Technical Specs : Nano-particles, ultrapure, low-monomer & powder grades.
Ingredient(s) : Poly-DL-Lactic-co-Glycolic Acid
Dosage Form : Tablet
Grade : Oral, Parenteral
Application : Controlled & Modified Release
Excipient Details : PLLA-PEG used in the synthesis of targeted nanoparticles which are used for differential delivery and controlled release of drugs.
Pharmacopoeia Ref : NA
Technical Specs : Nano-particles, ultrapure, low-monomer & powder grades
Ingredient(s) : Poly L Lactide
Dosage Form : Tablet
Grade : Oral
Application : Fillers, Diluents & Binders
Excipient Details : Copovidone is used as a film-former and binding agent in oral solids such as tablets and capsules.
Dosage Form : Tablet
Grade : Oral
Application : Granulation
Excipient Details : Crospovidone is used as a granulating agent in pharmaceutical formulations such as tablets, granules, and pellets.
Dosage Form : Tablet
Grade : Oral
Dosage Form : Tablet
Grade : Oral
Application : Coating Systems & Additives
Excipient Details : Novomix is used as a ready mix film coating system in the production of pharmaceutical tablets.
Dosage Form : Tablet
Grade : Oral
Dosage Form : Capsule
Grade : Oral
Application : Fillers, Diluents & Binders
Dosage Form : Tablet
Grade : Oral
Dosage Form : Tablet
Grade : Oral
Application : Disintegrants & Superdisintegrants
Dosage Form : Tablet
Grade : Oral
Application : Lubricants & Glidants
Dosage Form : Solution
Grade : Oral, Topical
Application : Solubilizers
Excipient Details : Hydrosol 50 is used as a solubilizer and emulsifying agent in oral and topical liquid and semi-solid dosage forms.
Pharmacopoeia Ref : USP/NF
Technical Specs : N/A
Ingredient(s) : Polyoxyl 40 Hydrogenated Castor Oil
Excipients by Applications
Dosage Form : Capsule, Granule / Pellet, Tablet
Grade : Oral
Category : Direct Compression, Disintegrants & Superdisintegrants
Application : Direct Compression, Disintegrants & Superdisintegrants
Excipient Details : Solvostar (Sodium Starch Glycolate) is used as a superdisintegrant and directly compressible excipient in tablets, capsules, suspensions, and pellets.
Pharmacopoeia Ref : IP/BP/EP/USP-NF
Technical Specs : Solvostar 2% to 8%
Ingredient(s) : Sodium Starch Glycolate
Grade : Oral
Category : Disintegrants & Superdisintegrants, Fillers, Diluents & Binders
Brand Name : Innogel 9000/9500
Application : Disintegrants & Superdisintegrants, Fillers, Diluents & Binders
Excipient Details : Innogel 9000/9500 (Pregelatinized Starch) is used as filler, binder, disintegrant, and superdisintegrant in tablets and capsules.
Pharmacopoeia Ref : IP/BP/EP/USP-NF
Technical Specs : NA
Ingredient(s) : Corn Starch, Pregelatinized
Dosage Form : Capsule, Granule / Pellet, Tablet
Grade : Oral
Category : Disintegrants & Superdisintegrants
Dosage Form : Capsule, Granule / Pellet, Tablet
Grade : Oral
Category : Disintegrants & Superdisintegrants
Application : Disintegrants & Superdisintegrants
Excipient Details : Sallyso (Croscarmellose Sodium) is used as a disintegrating agent in tablets, capsules & granules for enhancing API dissolution and bioavailability.
Pharmacopoeia Ref : IP/BP/EP/USP-NF
Technical Specs : Sallyso 0.5 to 3.0%
Ingredient(s) : Croscarmellose Sodium
Grade : Oral
Category : Co-Processed Excipients, Direct Compression, Disintegrants & Superdisintegrants, Fillers, Diluents & Binders, Lubricants & Glidants
Application : Co-Processed Excipients, Direct Compression, Disintegrants & Superdisintegrants, Fillers, Diluents & Binders, Lubricants & Glidants
Excipient Details : ProBlend (Microcrystalline Cellulose) is used as a filler, binder, glidant, DC & co-processed excipient in tablets, capsules, and MUPS formulations.
Global Sales Information
Market Place
Patents & EXCLUSIVITIES
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A Hydrocodone manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Hydrocodone, including repackagers and relabelers. The FDA regulates Hydrocodone manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Hydrocodone API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Hydrocodone manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Hydrocodone supplier is an individual or a company that provides Hydrocodone active pharmaceutical ingredient (API) or Hydrocodone finished formulations upon request. The Hydrocodone suppliers may include Hydrocodone API manufacturers, exporters, distributors and traders.
click here to find a list of Hydrocodone suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Hydrocodone DMF (Drug Master File) is a document detailing the whole manufacturing process of Hydrocodone active pharmaceutical ingredient (API) in detail. Different forms of Hydrocodone DMFs exist exist since differing nations have different regulations, such as Hydrocodone USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Hydrocodone DMF submitted to regulatory agencies in the US is known as a USDMF. Hydrocodone USDMF includes data on Hydrocodone's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Hydrocodone USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Hydrocodone suppliers with USDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Hydrocodone Drug Master File in Korea (Hydrocodone KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Hydrocodone. The MFDS reviews the Hydrocodone KDMF as part of the drug registration process and uses the information provided in the Hydrocodone KDMF to evaluate the safety and efficacy of the drug.
After submitting a Hydrocodone KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Hydrocodone API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Hydrocodone suppliers with KDMF on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Hydrocodone as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Hydrocodone API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Hydrocodone as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Hydrocodone and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Hydrocodone NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Hydrocodone suppliers with NDC on PharmaCompass.
Hydrocodone Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Hydrocodone GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Hydrocodone GMP manufacturer or Hydrocodone GMP API supplier for your needs.
A Hydrocodone CoA (Certificate of Analysis) is a formal document that attests to Hydrocodone's compliance with Hydrocodone specifications and serves as a tool for batch-level quality control.
Hydrocodone CoA mostly includes findings from lab analyses of a specific batch. For each Hydrocodone CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Hydrocodone may be tested according to a variety of international standards, such as European Pharmacopoeia (Hydrocodone EP), Hydrocodone JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Hydrocodone USP).
LOOKING FOR A SUPPLIER?